Alnylam Pharmaceuticals | ALNY - Ebitda





Ebitda تغيير تاريخ
Acadia Pharmaceuticals USD 40.99M 42.62M 2026-06
Agios Pharmaceuticals USD -109.2M 540K 2026-06
Alnylam Pharmaceuticals USD 360.27M 114.93M 2026-09
Amgen USD 5.8B 1.25B 2026-09
Arrowhead Research USD -147.68M 40.33M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
BioMarin Pharmaceutical USD 54.32M 167.99M 2026-09
Incyte USD 778.57M 410.6M 2026-06
Ionis Pharmaceuticals USD -95.22M 9.99M 2026-09
Moderna USD -687M 571M 2026-06
Neurocrine Biosciences USD 375.3M 185.4M 2026-09
Novartis USD 5.36B 45M 2026-09
PTC Therapeutics USD 161.9M 99.92M 2026-06
Regeneron Pharmaceuticals USD 1.66B 695.2M 2026-06
Sanofi EUR 6.66B 4.99B 2026-09
Sarepta Therapeutics USD -3.14M 33.31M 2026-09
Takeda JPY 369.75B 5.29B 2026-09
Tectonic Therapeutic USD -21.18M 365K 2025-12
Ultragenyx Pharmaceutical USD -61M 94M 2026-06
Vertex Pharmaceuticals USD 888.6M 436.6M 2026-09
Xencor USD 25.1M 59.73M 2026-09